Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia
Authors:
- J. PachonJPJ. Pachon
- Cristina PichardoCPCristina Pichardo
- Lucila CuberosLCLucila Cuberos
- José Ibáñez-MartínezJIJosé Ibáñez-Martínez
- A. Garcia-CurielAGA. Garcia-Curiel
- Francisco J. CaballeroFCFrancisco J. Caballero
- Ignacio MorenoIMIgnacio Moreno
- M. E. Jimenez-MejiasMJM. E. Jimenez-Mejias
- María- JesúsMJMaría- Jesús
- J PachónJPJ Pachón
- JerónimoJEJerónimo
Open Access
- 1 April 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 45 (4) , 493-501
Abstract
Acinetobacter baumannii is a common cause of nosocomial pneumonia and other nosocomial infections. Multiresistant A. baumannii has also a high prevalence, which can make effective treatment difficult. We designed a new model of A. baumannii experimental pneumonia using C57BL/6 immunocompetent mice. This model was used to compare the efficacy of imipenem, doxycycline and amikacin in monotherapy, and the combination of imipenem plus amikacin and doxycycline plus amikacin. Doxycycline plus amikacin were synergic in vitro after 24 h incubation, whereas imipenem plus amikacin showed no in vitro synergy. The number of sterile lungs and the lung clearance of A. baumannii were greater in the group treated with imipenem than in those treated with amikacin or doxycycline in monotherapy (P < 0.05). The combination of imipenem plus amikacin and doxycycline plus amikacin was no more effective than imipenem alone in the clearance of organisms from lungs (2.42 ± 1.46 cfu/g versus 2.7 ± 1.5 cfu/g versus 1.23 ± 1.02 cfu/g). These results suggest that the addition of amikacin does not improve the results obtained by imipenem monotherapy. Doxycycline plus amikacin is an alternative to imipenem in the therapy of A. baumannii pneumonia.Keywords
This publication has 21 references indexed in Scilit:
- Investigation of a Multiyear Multiple Critical Care Unit Outbreak Due to Relatively Drug-Sensitive Acinetobacter baumannii: Risk Factors and Attributable MortalityThe Journal of Infectious Diseases, 1996
- Relevance of Digestive Tract Colonization in the Epidemiology of Nosocomial Infections Due to Multiresistant Acinetobacter baumanniiClinical Infectious Diseases, 1996
- Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic FeaturesClinical Infectious Diseases, 1996
- The Effect of Late-Onset Ventilator-Associated Pneumonia in Determining Patient MortalityChest, 1995
- Nosocomial Acquisition of Multiresistant Acinetobacter baumannii: Risk Factors and PrognosisClinical Infectious Diseases, 1995
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994
- Infections Caused by Imipenem-Resistant Acinetobacter calcoaceticus Biotype anitratusThe Journal of Infectious Diseases, 1993
- In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 1993
- Nosocomial Pneumonia in Patients Receiving Continuous Mechanical Ventilation: Prospective Analysis of 52 Episodes with Use of a Protected Specimen Brush and Quantitative Culture TechniquesAmerican Review of Respiratory Disease, 1989
- EndemicAcinetobacter anitratus in a surgical intensive care unit: Mechanical ventilators as reservoirEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988